Ledger.Open graph →
SEC Form D · filed August 8, 2018

Abrexa Pharmaceuticals, Inc

Offering
$7.6M
Sold
$7.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Kathryn Fantauzzi · Pittsburgh, PADirectorRichard J. Walters Ii · New York, NYExec · DirectorJack A. Theeler · Mitchell, SDDirectorJay Manni · San Jose, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗